Log In
Print
BCIQ
Print
Print this Print this
 

Premiplex, mecasermin rinfabate (iPlex) (SHP607) (formerly HGT-ROP-001)

Also known as: Insulin-like growth factor-1/binding protein 3 (IGF-1/BP3) (formerly SomatoKine)

  Manage Alerts
Collapse Summary General Information
Company Insmed Inc.
DescriptionComplex of insulin-like growth factor-1 (IGF-1) and its principal binding protein, IGF binding protein 3 (IGFBP3)
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221) ; Insulin-like growth factor (IGF) binding protein 3 (IGFBP3)
Mechanism of ActionInsulin-like growth factor-1 (IGF-1) receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationRetinopathy of prematurity
Indication DetailsTreat retinopathy of prematurity (ROP)
Regulatory Designation

U.S. - Fast Track (Treat retinopathy of prematurity (ROP));
U.S. - Orphan Drug (Treat retinopathy of prematurity (ROP));
EU - Orphan Drug (Treat retinopathy of prematurity (ROP))

Partner

Shire plc


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today